These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 3948304)

  • 1. Pharmacokinetics of high-dose melphalan in children and adults.
    Gouyette A; Hartmann O; Pico JL
    Cancer Chemother Pharmacol; 1986; 16(2):184-9. PubMed ID: 3948304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of high-dose intravenous melphalan in children and adults with forced diuresis. Report in 26 cases.
    Ardiet C; Tranchand B; Biron P; Rebattu P; Philip T
    Cancer Chemother Pharmacol; 1986; 16(3):300-5. PubMed ID: 3516430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose melphalan in children with advanced malignant disease. A pharmacokinetic study.
    Ninane J; Baurain R; de Selys A; Trouet A; Cornu G
    Cancer Chemother Pharmacol; 1985; 15(3):263-7. PubMed ID: 4053270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.
    Lazarus HM; Herzig RH; Graham-Pole J; Wolff SN; Phillips GL; Strandjord S; Hurd D; Forman W; Gordon EM; Coccia P
    J Clin Oncol; 1983 Jun; 1(6):359-67. PubMed ID: 6366139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of melphalan in children following high-dose intravenous injection.
    Taha IA; Ahmad RA; Rogers DW; Pritchard J; Rogers HJ
    Cancer Chemother Pharmacol; 1983; 10(3):212-6. PubMed ID: 6861266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of food on oral melphalan absorption.
    Reece PA; Kotasek D; Morris RG; Dale BM; Sage RE
    Cancer Chemother Pharmacol; 1986; 16(2):194-7. PubMed ID: 3948305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of high dose melphalan.
    Hersh MR; Ludden TM; Kuhn JG; Knight WA
    Invest New Drugs; 1983; 1(4):331-4. PubMed ID: 6678879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of high-dose intravenous melphalan in patients undergoing peripheral blood hematopoietic progenitor-cell transplantation.
    Pinguet F; Martel P; Fabbro M; Petit I; Canal P; Culine S; Astre C; Bressolle F
    Anticancer Res; 1997; 17(1B):605-11. PubMed ID: 9066587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of intravenous melphalan.
    Alberts DS; Chang SY; Chen HS; Moon TE; Evans TL; Furner RL; Himmelstein K; Gross JF
    Clin Pharmacol Ther; 1979 Jul; 26(1):73-80. PubMed ID: 445964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral melphalan kinetics.
    Alberts DS; Chang SY; Chen HS; Evans TL; Moon TE
    Clin Pharmacol Ther; 1979 Dec; 26(6):737-45. PubMed ID: 498715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diuretic effect of furosemide in acute glomerulonephritis.
    Pruitt AW; Boles A
    J Pediatr; 1976 Aug; 89(2):306-9. PubMed ID: 940030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose intravenous melphalan: a review.
    Samuels BL; Bitran JD
    J Clin Oncol; 1995 Jul; 13(7):1786-99. PubMed ID: 7602368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of systemic hyperthermia on melphalan pharmacokinetics in mice.
    Honess DJ; Donaldson J; Workman P; Bleehen NM
    Br J Cancer; 1985 Jan; 51(1):77-84. PubMed ID: 3966973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [High-dose chemotherapy with autologous bone marrow transplantation in children with high-risk malignant neoformations].
    Aleĭnikova OV; Strongin IuS; Pochetukhin KV
    Vopr Onkol; 2002; 48(3):327-30. PubMed ID: 12455356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mathematical model for reconstitution of granulopoiesis after high dose chemotherapy with autologous stem cell transplantation.
    Østby I; Rusten LS; Kvalheim G; Grøttum P
    J Math Biol; 2003 Aug; 47(2):101-36. PubMed ID: 12883857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma.
    Bosanquet AG; Gilby ED
    Eur J Cancer Clin Oncol; 1982 Apr; 18(4):355-62. PubMed ID: 6889512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marrow autotransplantation accelerates haematological recovery in patients with malignant melanoma treated with high-dose melphalan.
    McElwain TJ; Hedley DW; Burton G; Clink HM; Gordon MY; Jarman M; Juttner CA; Millar JL; Milsted RA; Prentice G; Smith IE; Spence D; Woods M
    Br J Cancer; 1979 Jul; 40(1):72-80. PubMed ID: 383125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
    Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH
    Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autologous bone marrow transplantation contributes to haemopoietic recovery in children with solid tumours treated with high dose melphalan.
    Kingston JE; Malpas JS; Stiller CA; Pritchard J; McElwain TJ
    Br J Haematol; 1984 Dec; 58(4):589-95. PubMed ID: 6394042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors.
    Diaz MA; Vicent MG; Madero L
    Bone Marrow Transplant; 1999 Dec; 24(11):1157-9. PubMed ID: 10642802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.